<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/1AF05D17-9958-4718-BE38-A879F220712E"><gtr:id>1AF05D17-9958-4718-BE38-A879F220712E</gtr:id><gtr:name>Interpharm Investments Limited</gtr:name><gtr:address><gtr:line1>STUDIO 1, COLE STREET STUDIOS , 6-8 COLE STREET</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>SE1 4YH</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1AF05D17-9958-4718-BE38-A879F220712E" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>1AF05D17-9958-4718-BE38-A879F220712E</gtr:id><gtr:name>Interpharm Investments Limited</gtr:name><gtr:address><gtr:line1>STUDIO 1, COLE STREET STUDIOS , 6-8 COLE STREET</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>SE1 4YH</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>61092.0</gtr:offerGrant><gtr:projectCost>88118.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03F6B2E2-6FC1-43D1-91F6-0AA325FD7FC3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>03F6B2E2-6FC1-43D1-91F6-0AA325FD7FC3</gtr:id><gtr:name>Phytoquest Limited</gtr:name><gtr:address><gtr:line1>C/O IBERS , PLAS GOGERDDAN</gtr:line1><gtr:city>ABERYSTWYTH</gtr:city><gtr:postCode>SY23 3EB</gtr:postCode><gtr:region>Wales</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>8679.0</gtr:offerGrant><gtr:projectCost>11572.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/293E9D3D-228A-4CCC-8763-FF0093CBC1B2"><gtr:id>293E9D3D-228A-4CCC-8763-FF0093CBC1B2</gtr:id><gtr:firstName>MARIA-CRISTINA</gtr:firstName><gtr:surname>COMELLI</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=131486"><gtr:id>B39D271F-7A4B-4C47-846D-941F7B8F7A6E</gtr:id><gtr:title>Sourcing and testing an immune system stimulant derived from an edible tropical fruit</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>131486</gtr:grantReference><gtr:abstractText>InterPharm Investments Ltd is a ?search and development? company focussed on ?Foods for Special Medical Purposes?. These are products for the dietary management of a medical condition. We have identified an edible fruit which contains a bioactive ingredient with distinctive beneficial activity on the human immune system, and we wish to investigate whether it is possible to develop a commercially viable supply of an extract from the fruit. The proposed project entails development of an extraction/enrichment method followed by a dose-ranging study in a suitable animal model, to provide guidance for a subsequent dose-ranging study in people. The project also includes research on the history and extent of consumption of the fruit in Europe, as such information is a necessary part of an application for regulatory approval. Finished products containing the bioactive would be sold globally through marketing partners.</gtr:abstractText><gtr:fund><gtr:end>2015-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2013-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>69771</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">131486</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>